옛 화면은 좌우로 밀어 볼 수 있습니다.

▒▒▒▒ 보건복지부 약물대사유전체연구센터 ▒▒▒▒
 
 
 

 

HOME < 연구성과 < 논문실적
 
   
 
  지원과제 PRCDM
  저자명 Gwak J, Cho M, Gong SJ, Won J, Kim DE, Kim EY, Lee SS, Kim M, Kim TK, Shin JG, Oh S.
  학회정보 J Cell Sci. 2006 Nov 15;119(Pt 22):4702-9.
  제 목 Protein-kinase-C-mediated {beta}-catenin phosphorylation negatively regulates the Wnt/{beta}-catenin pathway.
  LINK www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=..
  게시일 2006-12-05 13:29:53
  년도 2006-International
  내용

Normally, the Wnt/beta-catenin pathway controls developmental processes and homeostasis, but abnormal activation of this pathway is a frequent event during the development of cancer. The key mechanism in regulation of the Wnt/beta-catenin pathway is the amino-terminal phosphorylation of beta-catenin, marking it for proteasomal degradation. Here we present small-molecule-based identification of protein kinase C (PKC)-mediated beta-catenin phosphorylation as a novel mechanism regulating the Wnt/beta-catenin pathway. We used a cell-based chemical screen to identify A23187, which inhibits the Wnt/beta-catenin pathway. PKC was activated by A23187 treatment and subsequently phosphorylated N-terminal serine (Ser) residues of beta-catenin, which promoted beta-catenin degradation. Moreover, the depletion of PKCalpha inhibited the phosphorylation and degradation of beta-catenin. Therefore, our findings suggest that the PKC pathway negatively regulates the beta-catenin level outside of the Wnt/beta-catenin pathway.

PMID: 17093267